Quantitative Short Echo Time ¹H-MR Spectroscopy of Untreated Pediatric Brain Tumors: Preoperative Diagnosis and Characterization

References

1. ↵
   Wang Z, Sutton LN, Cnaan A, et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 1995;16:1821–33

   Abstract
2. ↵
   Sutton LN, Wang Z, Gusnard D, et al. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31:195–202

   PubMedWeb of Science
3. Lazareff JA, Bockhorst KH, Curran J, et al. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 1998;43:809–17

   CrossRefPubMed
4. ↵
   Lazareff JA, Olmstead C, Bockhorst KH, et al. Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas. Childs Nerv Syst 1996;12:130–35

   CrossRefPubMed
5. ↵
   Horska A, Ulug AM, Melhem ER, et al. Proton magnetic resonance spectroscopy of choroid plexus tumors in children. J Magn Reson Imaging 2001;14:78–82

   CrossRefPubMed
6. ↵
   Tzika AA, Vigneron DB, Dunn RS, et al. Intracranial tumors in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences. Neuroradiology 1996;38:254–63

   PubMed
7. ↵
   Hwang JH, Egnaczyk GF, Ballard E, et al. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 1998;19:535–40

   Abstract
8. Girard N, Wang ZJ, Erbetta A, et al. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children. Neuroradiology 1998;40:121–25

   CrossRefPubMedWeb of Science
9. Arle JE, Morriss C, Wang ZJ, et al. Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks. J Neurosurg 1997;86:755–61

   CrossRefPubMed
10. ↵
    Dezortova M, Hajek M, Cap F, et al. Comparison of MR spectroscopy and MR imaging with contrast agent in children with cerebral astrocytomas. Childs Nerv Syst 1999;15:408–12

    PubMed
11. ↵
    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79

    CrossRefPubMedWeb of Science
12. ↵
    Moreno-Torres A, Martinez-Perez I, Baquero M, et al. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma. Neurosurgery 2004;55:824–29

    PubMedWeb of Science
13. Wilke M, Eidenschink A, Muller-Weihrich S, et al. MR diffusion imaging and 1H spectroscopy in a child with medulloblastoma: a case report. Acta Radiol 2001;42:39–42

    FREE Full Text
14. ↵
    Tong Z, Yamaki T, Harada K, et al. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004;22:1017–24

    CrossRefPubMedWeb of Science
15. ↵
    Seeger U, Klose U, Mader I, et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19–28

    CrossRefPubMedWeb of Science
16. ↵
    Auer DP, Gossl C, Schirmer T, et al. Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46:615–18

    CrossRefPubMed
17. ↵
    Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson 1993;102:1–8

    CrossRef
18. ↵
    Kreis R. Quantitative localized 1H MR spectroscopy for clinical use. Prog NMR Spectroscopy 1997;31:155–95

    CrossRef
19. ↵
    Kreis R, Hofmann L, Kuhlmann B, et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48:949–58

    CrossRefPubMedWeb of Science
20. ↵
    Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449–58

    CrossRefPubMedWeb of Science
21. ↵
    Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223–32

    CrossRefPubMed
22. ↵
    Yates AJ, Becker LE, Sachs LA. Brain tumors in childhood. Childs Brain 1975;5:31–39
23. ↵
    Brown WD, Gilles FH, Tavare CJ, et al. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors. J Neuropathol Exp Neurol 1998;57:1035–40

    CrossRefPubMedWeb of Science
24. ↵
    Gilles FH, Brown WD, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors: Children Brain Tumor Consortium. Cancer 2000;88:1477–83

    CrossRefPubMed
25. ↵
    Kreis R, Ernst T, Ross B. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson 1993;102:9–19

    CrossRefWeb of Science
26. ↵
    Blüml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med 1999;42:643–54

    CrossRefPubMedWeb of Science
27. ↵
    Jope RS, Jenden DJ. Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. J Neurosci Res 1979;4:69–82

    CrossRefPubMedWeb of Science
28. ↵
    Albers MJ, Krieger MD, Gonzalez-Gomez I, et al. Proton-decoupled (31)P MRS in untreated pediatric brain tumors. Magn Reson Med 2005;53:22–29

    CrossRefPubMed
29. ↵
    Sabatier J, Gilard V, Malet-Martino M, et al. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol 1999;34:230–35

    CrossRefPubMedWeb of Science
30. ↵
    Usenius JP, Vainis P, Hernesmiemi J, et al. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63:1538–43

    PubMedWeb of Science
31. ↵
    Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 1991;4:47–52

    PubMedWeb of Science
32. ↵
    Podo F. Tumor phospholipid metabolism. NMR Biomed 1999;12:413–39

    CrossRefPubMedWeb of Science
33. ↵
    Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002;296:580–83

    CrossRefPubMedWeb of Science
34. ↵
    Astrakas LG, Zurakowski D, Tzika AA, et al. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 2004;10:8220–28

    Abstract/FREE Full Text
35. ↵
    Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992;24:123–26

    PubMedWeb of Science
36. ↵
    Negendank WG. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303–24

    PubMedWeb of Science
37. ↵
    Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem 1957;224:41–45

    FREE Full Text
38. ↵
    Baslow MH. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem 2000;75:453–59

    CrossRefPubMedWeb of Science
39. ↵
    Spector R, Lorenzo AV. Myo-inositol transport in the central nervous system. Am J Physiol 1975;228:1510–18

    Abstract/FREE Full Text
40. ↵
    Isaacks RE, Bender AS, Kim CY, et al. Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem Res 1994;19:331–38

    CrossRefPubMedWeb of Science
41. ↵
    Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645–49

    Abstract/FREE Full Text
42. ↵
    Sutton LN, Wehrli SL, Gennarelli L, et al. High-resolution 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J Neurosurg 1994;81:443–48

    PubMedWeb of Science
43. ↵
    Flint AC, Liu X, Kriegstein AR. Nonsynaptic glycine receptor activation during early neocortical development. Neuron 1998;20:43–53

    CrossRefPubMedWeb of Science
44. ↵
    Pasteur L. Experiences et vues nouvelles sur la nature des fermentations. Comp Rend Acad Sci 1861;52:1260–64
45. ↵
    Krebs HA. The Pasteur effect and the relations between respiration and fermentation. Essays Biochem 1972;8:1–34

    PubMed
46. ↵
    Lentner C. Geigy Scientific Tables.Vol. 1. Basel, Switzerland: Ciba-Geigy ;1981 :173
47. ↵
    Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497–504

    PubMedWeb of Science
48. ↵
    Ensenauer R, Thiel T, Schwab KO, et al. Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle. Mol Genet Metab 2004;82:208–13

    CrossRefPubMedWeb of Science
49. ↵
    Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res 1996;16:1533–38

    PubMedWeb of Science
50. ↵
    Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323–25

    CrossRefPubMedWeb of Science
51. ↵
    Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50:215–26

    CrossRefPubMed